Data / Drug companies / Octisalate, octocrylene, zinc oxide
Octisalate, octocrylene, zinc oxide: 6 companies and 8 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Octisalate, octocrylene, zinc oxide is listed in the FDA National Drug Code Directory by 6 companies, with 8 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; lotion, and the newest product started marketing on April 1, 2026.
The request: Get every company that lists octisalate, octocrylene, zinc oxide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 6
- Products
- 8
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 1
- Routes
- Topical
- Brand names
- Abib Dewy Tinted Sunscreen Glow Tube Deep, Abib Dewy Tinted Sunscreen Glow Tube Medium, Shiseido Ultimate Sun Protector, Sun Bum Signature Clear High Performance Sunscreen Broad Spectrum SPF 50 1.5 Oz, Abib Dewy Tinted Sunscreen Glow Tube Light, Sunstation Sport Sunscreen SPF 30, Sun Veil IlluminatingElixir Face Sunscreen SPF 38, Shade SPF30 Climate Control
- openFDA record search
- api.fda.gov
Companies that list octisalate, octocrylene, zinc oxide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fourcompany Co., LTD. | 3 | cream | Over the counter monograph drugs | April 1, 2026 |
| Impact Melanoma Inc | 1 | cream | Over the counter monograph drugs | March 19, 2025 |
| Koco Life LLC | 1 | lotion | Over the counter monograph drugs | January 15, 2026 |
| Micro Current Technology, Inc. | 1 | cream | Over the counter monograph drugs | June 1, 2025 |
| Shiseido Americas Corporation | 1 | cream | Over the counter monograph drugs | March 1, 2025 |
| Sun Bum, LLC | 1 | lotion | Over the counter monograph drugs | January 1, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 6 | 75% |
| Lotion | 2 | 25% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 8 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 5 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.